Clinical trial
Lay User Evaluation of the Panbio™ HCV Self Test: a Prospective, Multi-centre Observed Untrained User Study.
NCT06605573 is registered in ClinicalTrials.gov with Abbott Rapid Dx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lay User Evaluation of the Panbio™ HCV Self Test: a Prospective, Multi-centre Observed Untrained User Study.
- Lead sponsor
- Abbott Rapid Dx
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2024
- Completion date
- March 31, 2025
- Enrollment
- 1,185 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c (hcv)